Gsk Plc Stock Price Prediction

GLAXF Stock  USD 16.87  0.17  1.00%   
As of 14th of December 2024, the relative strength index (RSI) of GSK Plc's share price is approaching 41. This usually indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling GSK Plc, making its price go up or down.

Oversold Vs Overbought

41

 
Oversold
 
Overbought
The successful prediction of GSK Plc's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of GSK Plc and does not consider all of the tangible or intangible factors available from GSK Plc's fundamental data. We analyze noise-free headlines and recent hype associated with GSK plc, which may create opportunities for some arbitrage if properly timed.
Using GSK Plc hype-based prediction, you can estimate the value of GSK plc from the perspective of GSK Plc response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in GSK Plc to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying GSK because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

GSK Plc after-hype prediction price

    
  USD 16.87  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out GSK Plc Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GSK Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
12.3015.1017.90
Details

GSK Plc After-Hype Price Prediction Density Analysis

As far as predicting the price of GSK Plc at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GSK Plc or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of GSK Plc, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

GSK Plc Estimiated After-Hype Price Volatility

In the context of predicting GSK Plc's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on GSK Plc's historical news coverage. GSK Plc's after-hype downside and upside margins for the prediction period are 14.07 and 19.67, respectively. We have considered GSK Plc's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
16.87
16.87
After-hype Price
19.67
Upside
GSK Plc is not too volatile at this time. Analysis and calculation of next after-hype price of GSK plc is based on 3 months time horizon.

GSK Plc Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as GSK Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GSK Plc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with GSK Plc, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.34 
2.80
 0.00  
  0.03 
0 Events / Month
7 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
16.87
16.87
0.00 
0.00  
Notes

GSK Plc Hype Timeline

GSK plc is currently traded for 16.87. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. GSK is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.34%. %. The volatility of related hype on GSK Plc is about 2982.25%, with the expected price after the next announcement by competition of 16.84. About 41.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.11. GSK plc last dividend was issued on the 23rd of February 2023. The entity had 4:5 split on the 19th of July 2022. Assuming the 90 days horizon the next anticipated press release will be in a few days.
Check out GSK Plc Basic Forecasting Models to cross-verify your projections.

GSK Plc Related Hype Analysis

Having access to credible news sources related to GSK Plc's direct competition is more important than ever and may enhance your ability to predict GSK Plc's future price movements. Getting to know how GSK Plc's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how GSK Plc may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SNPHFSanten Pharmaceutical Co 0.00 0 per month 0.00 (0.09) 2.70 (4.37) 15.41 
OPHLYOno Pharmaceutical Co 0.00 0 per month 0.00 (0.25) 2.09 (2.42) 10.36 
GRFSGrifols SA ADR 0.55 7 per month 0.00 (0.12) 5.06 (4.47) 20.33 
PFEPfizer Inc 0.47 9 per month 0.00 (0.19) 2.07 (2.25) 8.17 
SNYSanofi ADR(0.06)9 per month 0.00 (0.34) 1.13 (2.08) 7.81 
RHHBYRoche Holding Ltd 0.00 0 per month 0.00 (0.23) 1.20 (2.02) 5.51 
NVSNovartis AG ADR(0.80)9 per month 0.00 (0.36) 1.12 (1.52) 6.05 
AMGNAmgen Inc(2.43)8 per month 0.00 (0.23) 1.85 (4.16) 9.43 
GILDGilead Sciences(1.36)9 per month 1.19  0.06  1.94 (1.82) 10.79 
RHHVFRoche Holding AG 0.00 0 per month 0.00 (0.17) 2.01 (2.35) 5.43 
AZNCFAstraZeneca PLC 0.00 0 per month 0.00 (0.14) 2.98 (4.11) 12.29 
RHHBFRoche Holding AG 0.00 0 per month 0.00 (0.06) 5.59 (5.97) 16.69 
NVSEFNovartis AG 0.00 0 per month 0.00 (0.12) 4.12 (4.25) 12.02 
BMYMPBristol Myers Squibb(0.34)3 per month 1.84  0.07  3.82 (4.97) 22.13 
BAYZFBayer AG 1.77 15 per month 0.00 (0.25) 2.96 (4.51) 21.44 
ALPMFAstellas Pharma 0.00 0 per month 0.00 (0.05) 5.72 (6.04) 20.76 
BMYBristol Myers Squibb 0.54 8 per month 1.29  0.08  2.23 (2.09) 14.39 
AZNAstraZeneca PLC ADR(0.03)9 per month 0.00 (0.24) 1.32 (2.78) 8.50 

GSK Plc Additional Predictive Modules

Most predictive techniques to examine GSK price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GSK using various technical indicators. When you analyze GSK charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About GSK Plc Predictive Indicators

The successful prediction of GSK Plc stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as GSK plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of GSK Plc based on analysis of GSK Plc hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to GSK Plc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to GSK Plc's related companies.

Story Coverage note for GSK Plc

The number of cover stories for GSK Plc depends on current market conditions and GSK Plc's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GSK Plc is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GSK Plc's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

GSK Plc Short Properties

GSK Plc's future price predictability will typically decrease when GSK Plc's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of GSK plc often depends not only on the future outlook of the potential GSK Plc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GSK Plc's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.1 B

Complementary Tools for GSK Pink Sheet analysis

When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets